D. E. Shaw & Co., Inc. Royalty Pharma PLC Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Royalty Pharma PLC stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 932,340 shares of RPRX stock, worth $23.5 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

932,340

Holding current value

$23.5 Million

% of portfolio

0.02%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$25.63 - $29.27 $23 Million - $26.3 Million	898,728 Added 2673.83%	932,340 $26.4 Million
Q2 2024 Aug 14, 2024	BUY	$26.26 - $29.9 $882,651 - $1 Million	33,612 New	33,612 $886,000
Q4 2023 Feb 14, 2024	SELL	$26.21 - $29.22 $10.1 Million - $11.2 Million	-384,459 Reduced 96.64%	13,387 $376,000
Q3 2023 Nov 14, 2023	SELL	$26.26 - $31.38 $755,132 - $902,363	-28,756 Reduced 6.74%	397,846 $10.8 Million
Q2 2023 Aug 14, 2023	BUY	$29.6 - $36.56 $2.86 Million - $3.54 Million	96,782 Added 29.34%	426,602 $13.1 Million
Q1 2023 May 15, 2023	SELL	$32.77 - $39.4 $10.2 Million - $12.2 Million	-310,904 Reduced 48.52%	329,820 $11.9 Million
Q4 2022 Feb 14, 2023	SELL	$39.17 - $44.04 $1.61 Million - $1.81 Million	-41,062 Reduced 6.02%	640,724 $25.3 Million
Q3 2022 Nov 14, 2022	BUY	$39.88 - $44.65 $21.2 Million - $23.7 Million	530,538 Added 350.77%	681,786 $27.4 Million
Q2 2022 Aug 15, 2022	BUY	$37.53 - $44.22 $2.63 Million - $3.09 Million	69,947 Added 86.03%	151,248 $6.36 Million
Q1 2022 May 16, 2022	BUY	$37.46 - $42.44 $3.05 Million - $3.45 Million	81,301 New	81,301 $3.17 Million
Q3 2021 Nov 15, 2021	SELL	$36.14 - $42.24 $1.95 Million - $2.28 Million	-54,095 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$39.85 - $46.63 $2.16 Million - $2.52 Million	54,095 New	54,095 $2.22 Million

Others Institutions Holding RPRX

# of Institutions

413

Shares Held

283M

Call Options Held

578K

Put Options Held

47.5K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $11B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account